TCBP to Implement ADS Ratio Change
Portfolio Pulse from
TC BioPharm (NASDAQ: TCBP) announced a change in its ADS ratio from 1 ADS representing 200 ordinary shares to 1 ADS representing 4,000 ordinary shares, effective February 10, 2025.
February 05, 2025 | 5:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
TC BioPharm is changing its ADS ratio from 1:200 to 1:4,000, which may affect the stock's liquidity and price per ADS.
The change in ADS ratio will increase the price per ADS, which could affect trading liquidity. However, it does not alter the underlying value of the company. Investors may react to the perceived change in stock price, but the fundamental value remains unchanged.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100